Cargando…
Sirolimus is effective in autoimmune lymphoproliferative syndrome-type III: A pedigree case report with homozygous variation PRKCD
Autoimmune lymphoproliferative syndrome (ALPS) usually presents in childhood with fever, nonmalignant splenomegaly, and lymphadenopathy along with cytopenia, which is caused by mutations in the FAS apoptotic pathway. The TCRαβ + CD4/CD8 double-negative T cells (DNT), one of required criteria of ALPS...
Autores principales: | Gu, Hao, Chen, Zhenping, Ma, Jie, Wang, Jing, Zhang, Rui, Wu, Runhui, Wang, Tianyou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252363/ https://www.ncbi.nlm.nih.gov/pubmed/34187243 http://dx.doi.org/10.1177/20587384211025934 |
Ejemplares similares
-
Case report: Effectiveness of sirolimus in a de novo FAS mutation leading to autoimmune lymphoproliferative syndrome-FAS and elevated DNT/Treg ratio
por: Gu, Hao, et al.
Publicado: (2022) -
Case report: Effectiveness of sirolimus in treating partial DiGeorge Syndrome with Autoimmune Lymphoproliferative Syndrome (ALPS)-like features
por: Gu, Hao, et al.
Publicado: (2023) -
Case report: Neonatal autoimmune lymphoproliferative syndrome with a novel pathogenic homozygous FAS variant effectively treated with sirolimus
por: Elgharbawy, Fawzia M., et al.
Publicado: (2023) -
GAK and PRKCD kinases regulate basal mitophagy
por: Munson, Michael J., et al.
Publicado: (2022) -
GAK and PRKCD are positive regulators of PRKN-independent mitophagy
por: Munson, Michael J., et al.
Publicado: (2021)